CVS Health Reportedly In Advanced Talks To Buy Signify Health For About $8 Bln

Drugstore chain owner CVS Health Corp (CVS) is in advanced talks to buy home-healthcare company Signify Health Inc (SGFY) for about $8 billion, the Wall Street Journal reported citing people familiar with the matter.

CVS appears to have beat out other potential buyers including Amazon.com Inc (AMZN) and UnitedHealth Group Inc (UNH), who had also been circling Signify for a deal. The deal could be announced soon, the Journal reported.

The report noted that there is still no guarantee that CVS will reach a deal for Signify, which has been exploring strategic alternatives since earlier this summer.

Bids for the company were due September 6, but the report has said that an eager buyer could make a move before then.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lidl US has recalled its 8.4 oz Favorina branded Advent Calendar, i.e., Premium Chocolate with a Creamy Filling, citing potential Salmonella contamination, the U.S. Food and Drug Administration said. The products were available for sale at Lidl stores between October 12, 2022 and December 5, 2022. They will have a BEST IF USED BY year of 2023, and barcode number of 4056489516965. Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary series for children in this age group. Kraft Heinz Foods Co. is recalling around 2,400 pounds of ready-to-eat or RTE ham and cheese loaf products citing possible cross-contamination with under-processed products, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced.
Follow RTT